Latest Competition News

Jameson Resources has released a 2025 feasibility update for its Crown Mountain Hard Coking Coal Project, confirming reserves and revealing a 200% increase in pre-tax NPV despite significant capital and operating cost inflation.

Farm Pride Foods has locked in a $27.57 million financing deal with NAB, refinancing existing debt and backing key capital projects to strengthen its growth trajectory.

Chrysos Corporation has secured a landmark Master Services Agreement with Newmont Corporation, marking its first PhotonAssay unit deployment at the Ahafo mine in Ghana. This deal signals growing adoption of Chrysos’ cutting-edge gold analysis technology among top-tier miners.

Dropsuite Limited’s shareholders have overwhelmingly endorsed the proposed acquisition by NinjaOne Australia, voting in favour of the scheme at a hybrid meeting. The deal, valued at A$5.90 per share, now awaits final Federal Court approval.

Augustus Minerals has executed a binding agreement to acquire a company holding a contested third in line licence application for the Mt Kare Gold Project in Papua New Guinea, a site with a historic resource of over 2 million ounces of gold. The acquisition positions Augustus to actively pursue tenure in a competitive and complex licensing environment.

Austco Healthcare has renewed its preferred supplier agreement with a major US healthcare provider, continuing supply of its Tacera nurse call systems to 180 hospitals across 30 states. This extension builds on a lucrative five-year partnership worth over A$49 million.

Australian Vanadium’s subsidiary VSUN Energy reports improved cost competitiveness for Project Lumina’s vanadium flow battery system, positioning it strongly in Australia’s growing long-duration energy storage market.

Jameson Resources has released a 2025 feasibility update for its Crown Mountain Hard Coking Coal Project, confirming reserves and revealing a doubling of project NPV despite inflationary cost pressures.

Macquarie Group Limited has announced a quarterly ordinary dividend of AUD 1.7124 per security on its perpetual capital notes, with a 35% franking rate and a total distribution yield of 6.79% per annum.

Acrux Limited, partnering with TruPharma, has introduced its Dapsone 7.5% Gel in the US, featuring a unique tube packaging that aims to improve patient convenience and reduce environmental impact.

GQG Partners reported a steady increase in funds under management to US$163.6 billion as of April 30, 2025, driven by strong inflows in International and U.S. Equity strategies.

AVITA Medical reveals a bold expansion plan targeting a $3.5 billion U.S. acute wound care market by 2025, driven by a multi-product portfolio and sustained revenue growth.